OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 05, 2017
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.
July 02, 2017
How has the bio/pharmaceutical contract manufacturing industry evolved over the years and what does the future hold?
As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.
The more pharma science and technology change, the more business and policy concerns stay the same.
June 16, 2017
SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.
June 14, 2017
Sartorius Stedim Biotech combined the company’s ambr 15 bioreactor system with the Nova BioProfile FLEX2 cell culture analyzer for laboratory experiments.
June 07, 2017
USP describes analytical and microbiology testing required for different types of pharmaceutical water.
June 05, 2017
Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.
Increased capacity at PPD’s Richmond, VA laboratory are designed to support customers’ vaccine development programs.